Mereo Biopharma Group Plc's total assets for Q3 2025 were $53.60M, a decrease of -14.42% from the previous quarter. MREO total liabilities were $7.00M for the fiscal quarter, a -17.15% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.